Trial · NCT07889804
Quality of Life in Patients With Post-Sepsis Syndrome
NCT07889804, Not yet recruiting, Efferon JSC
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Quality of Life in Patients With Post-Sepsis Syndrome. Trials, record NCT07889804. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07889804
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Quality of Life in Patients With Post-Sepsis Syndrome
- NCT number
- NCT07889804
- Status
- Not yet recruiting
- Enrollment
- 300 participants, estimated
- Lead sponsor
- Efferon JSC
- Conditions
- Sepsis
- Interventions
- Efferon LPS
- First posted
- 2026-10-22
- Last updated
- 2026-10-22
Source ClinicalTrials.gov
Registered outcomes4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Number of deaths and hospital readmissions during the 12-month follow-up period | 1-12 month | Patient status, including survival, hospital readmissions, and palliative care status, assessed during the 12-month follow-up period after hospital discharge |
| Secondary | Overall health status and quality of life during the post-sepsis period (PROMIS score) | 1-12 month | Patient-Reported Outcomes Measurement Information System (PROMIS Global-10) score. Higher T-scores indicate better health. A score of 50 represents the population mean. Scores above 50 indicate better-than-average health status. Scores from 40 to 50 indicate average to mildly reduced health status. Scores below 40 indicate reduced health status. |
| Secondary | Severity of depressive symptoms during the post-sepsis period (PHQ-9 score) | 1-12 month | The PHQ-9 score ranges from 0 to 27, with higher scores indicating greater severity of depressive symptoms. Scores of 0-4 indicate minimal or no depressive symptoms, 5-9 indicate mild depressive symptoms, 10-14 indicate moderate depressive symptoms, 15-19 indicate moderately severe depressive symptoms, and 20-27 indicate severe depressive symptoms. |
| Secondary | Severity of anxiety symptoms during the post-sepsis period (GAD-7 score) | 1-12 month | The GAD-7 score ranges from 0 to 21, with higher scores indicating greater severity of anxiety symptoms. Scores of 0-4 indicate minimal anxiety, 5-9 indicate mild anxiety, 10-14 indicate moderate anxiety, and 15-21 indicate severe anxiety. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07889804
GET https://conductscience.org/api/trials/v1/NCT07889804/registered